Anti-apoptotic potential of several antidiabetic medicinal plants of the eastern James Bay Cree pharmacopeia in cultured kidney cells
Open Access
- 30 January 2018
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 18 (1) , 37
Abstract
Our team has identified 17 Boreal forest species from the traditional pharmacopeia of the Eastern James Bay Cree that presented promising in vitro and in vivo biological activities in the context of type 2 diabetes (T2D). We now screened the 17 plants extracts for potential anti-apoptotic activity in cultured kidney cells and investigated the underlying mechanisms. MDCK (Madin-Darnby Canine Kidney) cell damage was induced by hypertonic medium (700 mOsm/L) in the presence or absence of maximal nontoxic concentrations of each of the 17 plant extracts. After 18 h’ treatment, cells were stained with Annexin V (AnnV) and Propidium iodide (PI) and subjected to flow cytometry to assess the cytoprotective (AnnV−/PI−) and anti-apoptotic (AnnV+/PI−) potential of the 17 plant extracts. We then selected a representative subset of species (most cytoprotective, moderately so or neutral) to measure the activity of caspases 3, 8 and 9. Gaultheria hispidula and Abies balsamea are amongst the most powerful cytoprotective and anti-apoptotic plants and appear to exert their modulatory effect primarily by inhibiting caspase 9 in the mitochondrial apoptotic signaling pathway. We conclude that several Cree antidiabetic plants exert anti-apoptotic activity that may be relevant in the context of diabetic nephropathy (DN) that affects a significant proportion of Cree diabetics.Keywords
Funding Information
- Canadian Institutes of Health Research (OP2144645)
This publication has 87 references indexed in Scilit:
- Diabetes and renal tubular cell apoptosisWorld Journal of Diabetes, 2013
- The Action of Antidiabetic Plants of the Canadian James Bay Cree Traditional Pharmacopeia on Key Enzymes of Hepatic Glucose HomeostasisEvidence-Based Complementary and Alternative Medicine, 2013
- Characterizing the cytoprotective activity of Sarracenia purpurea L., a medicinal plant that inhibits glucotoxicity in PC12 cellsBMC Complementary and Alternative Medicine, 2012
- Comprehensive Evidence-Based Assessment and Prioritization of Potential Antidiabetic Medicinal Plants: A Case Study from Canadian Eastern James Bay Cree Traditional MedicineEvidence-Based Complementary and Alternative Medicine, 2011
- A RP‐HPLC‐DAD‐APCI/MSD method for the characterisation of medicinal Ericaceae used by the Eeyou Istchee Cree First NationsPhytochemical Analysis, 2010
- BASP1 Promotes Apoptosis in Diabetic NephropathyJournal of the American Society of Nephrology, 2010
- Caspase activation pathways: some recent progressCell Death & Differentiation, 2009
- Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part IICanadian Journal of Physiology and Pharmacology, 2009
- Medicinal plants of Cree communities (Québec, Canada): antioxidant activity of plants used to treat type 2 diabetes symptomsThis article is one of a selection of papers published in this special issue (part 2 of 2) on the Safety and Efficacy of Natural Health Products.Canadian Journal of Physiology and Pharmacology, 2007
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999